Caffeic Acid Phenethyl Ester: Consequences of Its Hydrophobicity in the Oxidative Functions and Cytokine Release by Leukocytes
Overview
Authors
Affiliations
Numerous anti-inflammatory properties have been attributed to caffeic acid phenethyl ester (CAPE), an active component of propolis. NADPH oxidases are multienzymatic complexes involved in many inflammatory diseases. Here, we studied the importance of the CAPE hydrophobicity on cell-free antioxidant capacity, inhibition of the NADPH oxidase and hypochlorous acid production, and release of TNF-α and IL-10 by activated leukocytes. The comparison was made with the related, but less hydrophobic, caffeic and chlorogenic acids. Cell-free studies such as superoxide anion scavenging assay, triene degradation, and anodic peak potential (E pa) measurements showed that the alterations in the hydrophobicity did not provoke significant changes in the oxidation potential and antiradical potency of the tested compounds. However, only CAPE was able to inhibit the production of superoxide anion by activated leukocytes. The inhibition of the NADPH oxidase resulted in the blockage of production of hypochlorous acid. Similarly, CAPE was the more effective inhibitor of the release of TNF-α and IL-10 by Staphylococcus aureus stimulated cells. In conclusion, the presence of the catechol moiety and the higher hydrophobicity were essential for the biological effects. Considering the involvement of NADPH oxidases in the genesis and progression of inflammatory diseases, CAPE should be considered as a promising anti-inflammatory drug.
Hidalgo M, Railef B, Rodriguez V, Navarro C, Rubio V, Meneses-Pacheco J Redox Biol. 2025; 80:103507.
PMID: 39848056 PMC: 11794178. DOI: 10.1016/j.redox.2025.103507.
Modulatory effect of caffeic acid in alleviating diabetes and associated complications.
Ganguly R, Singh S, Jaiswal K, Kumar R, Pandey A World J Diabetes. 2023; 14(2):62-75.
PMID: 36926656 PMC: 10011896. DOI: 10.4239/wjd.v14.i2.62.
Development of a caffeic acid-phthalimide hybrid compound for NADPH oxidase inhibition.
Dos Santos W, Yoguim M, Gomes Dare R, da Silva-Filho L, Lautenschlager S, Ximenes V RSC Adv. 2022; 11(29):17880-17890.
PMID: 35480205 PMC: 9033209. DOI: 10.1039/d1ra01066b.
Natural products can be used in therapeutic management of COVID-19: Probable mechanistic insights.
Ali S, Alam M, Khatoon F, Fatima U, Elasbali A, Adnan M Biomed Pharmacother. 2022; 147:112658.
PMID: 35066300 PMC: 8769927. DOI: 10.1016/j.biopha.2022.112658.
Dermal Drug Delivery of Phytochemicals with Phenolic Structure via Lipid-Based Nanotechnologies.
Gugleva V, Ivanova N, Sotirova Y, Andonova V Pharmaceuticals (Basel). 2021; 14(9).
PMID: 34577536 PMC: 8471500. DOI: 10.3390/ph14090837.